Resources

US-based clinical-grade computational pathology solution provider Paige has secured CE mark for its Paige Prostate and Paige Insight solutions. Paige Prostate is a prostate cancer detection solution, while Paige Insight is an AI-powered digital pathology viewer that...

3D printing company Formlabs has announced the creation of a new dental-focused business unit. Formlabs Dental will use the new Form 3B printer and its associated platform, which comes with a new range of dental materials, a dedicated service team and software to help...

US-based medical genetics firm Invitae has signed a definitive agreement to acquire Clear Genetics, a software developer, to provide genetic services, for a total consideration of approximately $50m. Under the agreement, Invitae will pay approximately $25m in cash and...

Preventive cardiology researchers at UT Southwestern Medical Center in the US have found that a blood test for protein biomarkers could help to identify high-risk heart disease in patients currently not receiving treatment. Researchers collected data of approximately...

Duodenoscopes are currently used in around 500,000 procedures a year in the US, and are essential tools for diagnosing and treating illnesses in the pancreas and bile ducts. The minimally invasive, re-usable fibreoptic devices are lowered into the upper part of the...

Just one month after ending a nine-year partnership with AbbVie, Reata Pharmaceuticals is delivering phase 3 data for its lead program in a rare form of chronic kidney disease. Patients who received the drug had better kidney function after 48 weeks of treatment and...

Regenxbio is taking the FDA to court over a clinical hold. The lawsuit alleges the FDA imposed the hold “without notice or explanation” and has since “rebuffed” Regenxbio’s repeated requests for an explanation of the regulatory action.

The genetic testing firm Invitae aims to expand its ability to provide personal guidance alongside its DNA test results—through the planned, $50 million acquisition of Clear Genetics, developers of digital counseling software.

Bolt Biotherapeutics, founded by Stanford immuno-oncology veteran Edgar Engleman, is developing new class of cancer drugs called immune stimulating antibody conjugates. Backed by fresh data from animal trials of its lead drug, a tumor-targeting antibody connected to...

BOSTON—Gilead’s nonalcoholic steatohepatitis (NASH) prospect selonsertib may have failed two phase 3 studies, but the company is putting the data from those studies to work. It presented three abstracts at the annual meeting of the American Association for...

Brian MacDonald’s original foray into treating iron dysregulation by injecting hepcidin, a small peptide hormone key for iron homeostasis, didn’t quite get off the ground. This time, the former GSK executive is taking a fresh approach — by regulating...

Due to meetings in London on a Friday and in Dortmund on the following Monday, I spent the weekend in London.  As I walked the streets appreciating its history, I could not help but think of the history of medicine, as well.  Images of leeches and...

Accurate low-flow measurements are critical for drug delivery and biotech studies.

Building a leading gene therapy pipeline in under two years (and a lot of air miles): how to persevere and make the calls that matter. Throughout a career in business development I’ve sat at every seat at the negotiating table, but I count my experience building...

Polyether ether ketone is an ideal choice for products in demanding applications.

Nearly two years ago, Nessan Bermingham, Ph.D., handed the reins of Intellia Therapeutics over to John Leonard, M.D., the R&D chief who had built the company alongside him. After a break, he landed at Atlas Venture, the VC firm that helped launch...

Keeping athletes safe, the elderly mobile, and workers uninjured is a challenge, but it isn’t stopping these companies from finding innovative solutions.

Factors that make for effective Wi-Fi include ample range, high throughput, low packet error rate, and suitable coexistence—all of which can be enhanced via 802.11ac.

The scientific founder and CEO of Cambridge startup Dyne Therapeutics has hired a new CEO — a former CFO with experience in public stock offerings. Read more. The post With eyes on IPO, muscular dystrophy startup names new CEO appeared first on Atlas Venture.

XP Power’s ALM150 and ALM200 power supplies operate at temperatures between 0 to +60°C and deliver their full rated power at ambient temperatures up to +40°C.

“Time flies when you’re having fun.” That’s how I feel as I reflect on the first three years of the growth of Kyn Therapeutics. So much has happened since my R&D colleague Michelle Zhang and I moved into the seed space at Atlas Venture (see...

AnalystView Market Insights predicts global reprocessed medical device market to grow at 17.4 percent and reach $5.6 billion by 2025. “The global reprocessed medical devices market is expected to grow at the growth rate of 17.4% to reach USD 5.6 billion by 2025....

Commonly Reprocessed Medical Devices The post Commonly Reprocessed Devices, AMDR Overview appeared first on AMDR.

Just five months after Novartis put down $310 million for IFM Therapeutics’ inflammation-focused unit, the Big Pharma has come back for more. This time, it is teaming up with IFM Due, the subsidiary IFM created to develop treatments targeting the cGAS...

One of the joys of building a company is that meeting one’s milestones routinely places us in positions that are new, where past experience may not be a guide.  Our ability to navigate growth is highly dependent on building a team that’s ready to take...